Related references
Note: Only part of the references are listed.Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC
Jennifer Schneider et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases
Masahiro Kanai et al.
NATURE GENETICS (2018)
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
N. S. Abul-Husn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes
Viktoria Gusarova et al.
NATURE COMMUNICATIONS (2018)
Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease
Connor A. Emdin et al.
NATURE COMMUNICATIONS (2018)
Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling
Connor A. Emdin et al.
CIRCULATION (2018)
Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies
Wei Zhou et al.
NATURE GENETICS (2018)
HCV-Associated Liver Fibrosis and HSD17B13
Fredegonde About et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
Sun-Gou Ji et al.
NATURE GENETICS (2017)
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
Nathan O. Stitziel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Exome-wide association study of plasma lipids in >300,000 individuals
Dajiang J. Liu et al.
NATURE GENETICS (2017)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Sumeet A. Khetarpal et al.
NATURE MEDICINE (2017)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
F. E. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A genome-wide association study identifies six novel risk loci for primary biliary cholangitis
Fang Qiu et al.
NATURE COMMUNICATIONS (2017)
The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
Zhengtao Liu et al.
SCIENTIFIC REPORTS (2017)
A reference panel of 64,976 haplotypes for genotype imputation
Shane McCarthy et al.
NATURE GENETICS (2016)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
New genetic loci link adipose and insulin biology to body fat distribution
Dmitry Shungin et al.
NATURE (2015)
Genetic studies of body mass index yield new insights for obesity biology
Adam E. Locke et al.
NATURE (2015)
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
Stephan Buch et al.
NATURE GENETICS (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Ron Do et al.
NATURE (2015)
Nitrite Reductase and Nitric-oxide Synthase Activity of the Mitochondrial Molybdopterin Enzymes mARC1 and mARC2
Courtney E. Sparacino-Watkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Yang-Lin Liu et al.
NATURE COMMUNICATIONS (2014)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
Validating therapeutic targets through human genetics
Robert M. Plenge et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The Mitochondrial Amidoxime-reducing Component (mARC1) Is a Novel Signal-anchored Protein of the Outer Mitochondrial Membrane
Julian M. Klein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ischemic Heart Disease Mortality and Morbidity Rates in Former Drinkers: A Meta-Analysis
Michael Roerecke et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C
Luca Valenti et al.
HEPATOLOGY (2011)
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
John C. Chambers et al.
NATURE GENETICS (2011)
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations
Joshua C. Denny et al.
BIOINFORMATICS (2010)
METAL: fast and efficient meta-analysis of genomewide association scans
Cristen J. Willer et al.
BIOINFORMATICS (2010)
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans
Anna C. Need et al.
GENOME BIOLOGY (2009)
Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study
Elizabeth K. Speliotes et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
The Fourth Molybdenum Containing Enzyme mARC: Cloning and Involvement in the Activation of N-Hydroxylated Prodrugs
Sanja Gruenewald et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme
Antje Havemeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Carcinogenesis of primary liver malignancies
R Dürr et al.
LANGENBECKS ARCHIVES OF SURGERY (2000)
Share Paper
